ergotamine has been researched along with bromocriptine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boess, FG; Monsma, FJ; Sleight, AJ | 1 |
| Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
| Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Berde, B | 1 |
| Loeffler, LJ; Schran, HF; Schwarz, HJ; Talbot, KC | 1 |
| Loizzo, A; Longo, VG | 1 |
| Häring, N; Jaeger, H; Salama, Z | 1 |
| Kanto, J | 1 |
| Lang, WJ; Woodman, OL | 1 |
| Jenkins, JS; Prysor-Jones, RA | 1 |
| Casy, AF | 2 |
| Kawakami, H; Nakamura, S; Tanaka, K; Yamashita, H; Zhang, YX | 1 |
| Larson, BT; Rowell, PP | 1 |
2 review(s) available for ergotamine and bromocriptine
| Article | Year |
|---|---|
Pharmacology of ergot alkaloids in clinical use.
Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction | 1978 |
Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
Topics: Absorption; Animals; Bromocriptine; Dihydroergotamine; Ergolines; Ergot Alkaloids; Ergotamine; Half-Life; Humans; Kinetics; Methysergide | 1983 |
14 other study(ies) available for ergotamine and bromocriptine
| Article | Year |
|---|---|
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
Topics: Adenylyl Cyclases; Amino Acid Substitution; Binding Sites; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Ligands; Lysergic Acid Diethylamide; Mutagenesis, Site-Directed; Mutation; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1998 |
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Specific radioimmunoassay of ergot peptide alkaloids in plasma.
Topics: Bromocriptine; Cross Reactions; Dihydroergotamine; Ergolines; Ergotamine; Humans; Radioimmunoassay; Structure-Activity Relationship | 1979 |
Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
Topics: Animals; Behavior, Animal; Brain; Bromocriptine; Dihydroergotoxine; Electroencephalography; Ergolines; Ergot Alkaloids; Ergotamine; Mice; Rabbits; Rats; Receptors, Dopamine | 1978 |
Triple stage quadrupole mass spectrometric determination of bromocriptine in human plasma with negative ion chemical ionization.
Topics: Biological Availability; Bromocriptine; Calibration; Chemical Phenomena; Chemistry; Ergotamine; Humans; Mass Spectrometry; Predictive Value of Tests; Reference Standards | 1988 |
Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Coronary Circulation; Dogs; Dopamine; Ergotamine; Female; Heart Rate; Male; Metoclopramide; Propranolol; Renal Circulation; Vasodilator Agents | 1982 |
Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
Topics: Animals; Bromocriptine; Cells, Cultured; DNA, Neoplasm; Ergot Alkaloids; Ergotamine; Female; Growth Hormone; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats | 1980 |
Rapid identification of ergot derivatives by 1H-NMR spectroscopy.
Topics: Bromocriptine; Ergolines; Ergotamine; Magnetic Resonance Spectroscopy; Reference Standards; Stereoisomerism | 1994 |
Mass spectrometry as an aid to the identification of ergots and dihydroergots: comparison of hard and soft ionization techniques.
Topics: Bromocriptine; Ergolines; Ergotamine; Ergotamines; Molecular Weight; Spectrometry, Mass, Fast Atom Bombardment | 1994 |
Effect of amino acid ergot alkaloids on glutamate transport via human glutamate transporter hGluT-1.
Topics: Amino Acid Transport System X-AG; Antioxidants; ATP-Binding Cassette Transporters; Biological Transport; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Drug Antagonism; Drug Synergism; Ergot Alkaloids; Ergotamine; Glutamic Acid; HeLa Cells; Humans; Kinetics; Time Factors; Tumor Cells, Cultured | 1998 |
Ergocryptine and other ergot alkaloids stimulate the release of [3H]dopamine from rat striatal synaptosomes.
Topics: Animals; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Ergonovine; Ergotamine; Male; Rats; Rats, Sprague-Dawley; Synaptosomes | 1999 |